GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan
· Delayed Price · Currency is TWD 18.75
-0.15 (-0.79%)
Mar 10, 2026, 1:30 PM CST
GeneReach Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,091 | 1,646 | 2,267 | 3,034 | 3,794 | 5,256 | Upgrade
|
| Market Cap Growth | -30.09% | -27.38% | -25.28% | -20.04% | -27.82% | 91.85% | Upgrade
|
| Enterprise Value | 1,065 | 1,453 | 2,018 | 2,509 | 3,642 | 5,180 | Upgrade
|
| Last Close Price | 18.90 | 28.65 | 39.45 | 51.29 | 60.29 | 80.07 | Upgrade
|
| PE Ratio | - | - | - | 13.71 | 10.07 | 20.43 | Upgrade
|
| Forward PE | - | 4.70 | 4.70 | 4.70 | 4.70 | 4.70 | Upgrade
|
| PS Ratio | 5.06 | 7.97 | 10.05 | 4.05 | 3.75 | 6.13 | Upgrade
|
| PB Ratio | 1.84 | 2.27 | 2.63 | 2.75 | 3.49 | 6.13 | Upgrade
|
| P/TBV Ratio | 1.92 | 2.34 | 2.77 | 2.87 | 3.65 | 6.54 | Upgrade
|
| P/FCF Ratio | - | - | - | 9.86 | 11.52 | 48.84 | Upgrade
|
| P/OCF Ratio | - | - | - | 8.48 | 10.87 | 30.95 | Upgrade
|
| EV/Sales Ratio | 4.95 | 7.04 | 8.95 | 3.35 | 3.60 | 6.04 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 8.57 | 6.86 | 13.00 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 10.40 | 7.55 | 14.58 | Upgrade
|
| EV/FCF Ratio | -28.22 | - | - | 8.15 | 11.06 | 48.14 | Upgrade
|
| Debt / Equity Ratio | 0.38 | 0.37 | 0.29 | 0.35 | 0.34 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 1.28 | 0.68 | 0.46 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 1.27 | 1.12 | 1.75 | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.20 | -0.29 | -0.32 | -0.27 | -0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.97 | 2.10 | 1.46 | -1.23 | -0.55 | -0.32 | Upgrade
|
| Net Debt / FCF Ratio | 0.95 | 4.84 | 4.08 | -1.16 | -0.89 | -1.17 | Upgrade
|
| Asset Turnover | 0.22 | 0.18 | 0.16 | 0.45 | 0.69 | 0.86 | Upgrade
|
| Inventory Turnover | 1.90 | 1.68 | 1.31 | 1.03 | 1.05 | 1.27 | Upgrade
|
| Quick Ratio | 1.46 | 1.92 | 2.55 | 2.09 | 3.09 | 1.96 | Upgrade
|
| Current Ratio | 2.40 | 2.48 | 3.07 | 2.78 | 4.24 | 3.26 | Upgrade
|
| Return on Equity (ROE) | -22.47% | -15.58% | -17.34% | 19.86% | 38.08% | 36.36% | Upgrade
|
| Return on Assets (ROA) | -6.19% | -7.31% | -10.24% | 9.12% | 20.61% | 22.20% | Upgrade
|
| Return on Invested Capital (ROIC) | -15.85% | -22.11% | -33.91% | 25.05% | 49.89% | 45.23% | Upgrade
|
| Return on Capital Employed (ROCE) | -14.30% | -15.90% | -23.60% | 19.50% | 34.30% | 35.70% | Upgrade
|
| Earnings Yield | -13.61% | -7.21% | -7.33% | 7.30% | 9.93% | 4.90% | Upgrade
|
| FCF Yield | -3.46% | -1.84% | -2.74% | 10.14% | 8.68% | 2.05% | Upgrade
|
| Dividend Yield | - | - | - | 2.34% | 6.03% | 3.12% | Upgrade
|
| Payout Ratio | - | - | - | 94.40% | 38.15% | - | Upgrade
|
| Buyback Yield / Dilution | 0.46% | - | 3.08% | -1.13% | -1.88% | -0.15% | Upgrade
|
| Total Shareholder Return | 0.46% | - | 3.08% | 1.21% | 4.15% | 2.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.